Anti-mouse CD19-InVivo

目录号：A2149         批次号: A214906

       克隆号：1D3

打印

Anti-mouse CD19-InVivo与小鼠 CD19 发生反应，CD19 是免疫球蛋白超家族的 B 细胞特异性 95 kDa 跨膜糖蛋白。

抗体信息

克隆号 1D3
配制 PBS, pH 7.0 Contains no stabilizers or preservatives
推荐同型对照 Rat IgG2a, κ
应用 Anti-mouse CD19-InVivo
来源 CHO
小鼠病原体检测 all targets tested yielded Negative Results: Theiler’s Murine Encephalomyelitis Virus, Ectromelia (Mousepox) Virus, Hantavirus, Polyomavirus, Sendai Virus, Mycoplasma pulmonis, Pneumonia Virus of Mice, K Virus, Mouse Parvovirus, Mouse Hepatitis Virus, Mouse Norovirus, Mouse Minute Virus, Mouse Cytomegalovirus, Mouse Adenovirus, Lactate Dehydrogenase-Elevating Virus, Reovirus Panel, Lymphocytic Choriomeningitis Virus, Mouse Rotavirus.
储存条件
(自收到货起)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
除菌 0.2 μM filtered
纯度 99%
蛋白浓度 8.02 mg/mL
内毒素 ＜1EU/mg

客户使用selleck产品的实验数据

Anti-mouse CD19-InVivo在文献中得到引用

Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction [ Signal Transduction and Targeted Therapy, May 16, 2025, 10(1):161] PubMed: 40374605
Oncolytic virus M1 reinvigorates CD8+ T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen [ Cellular and Molecular Immunology, March 4, 2026, 23(4):349-366] PubMed: 41781696
Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction [ Signal Transduction and Targeted Therapy, 2025 May 16, 10(1):161] PubMed: 40374605
Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction [ Signal Transduct Target Ther, 2025, 10(1):161] PubMed: 40374605

禁止用于人体及治疗！